US Stock MarketDetailed Quotes

MIRM Mirum Pharmaceuticals

Watchlist
  • 24.760
  • -1.070-4.14%
Close May 10 16:00 ET
  • 24.760
  • 0.0000.00%
Post 16:02 ET
1.17BMarket Cap-6620P/E (TTM)

About Mirum Pharmaceuticals Company

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Company Profile

SymbolMIRM
Company NameMirum Pharmaceuticals
Listing DateJul 18, 2019
Issue Price15.00
Founded2018
CEOMr. Christopher Peetz
MarketNASDAQ
Employees264
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address950 Tower Lane,Suite 1050
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-667-4085
Websitehttp://www.mirumpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Christopher Peetz
  • Director and Chief Executive Officer
  • 4.40M
  • Lara Longpre, PhD
  • Chief Development Officer
  • 1.51M
  • Peter Radovich
  • Chief Operating Officer and President
  • 1.56M
  • Eric H. Bjerkholt
  • Chief Financial Officer
  • --
  • Michael Grey
  • Chairman of the Board
  • 382.05K
  • Jody Howe
  • Director
  • --
  • Timothy P. Walbert
  • Director
  • --
  • Dr. Laurent Fischer, M.D.
  • Independent Director
  • 331.42K
  • Saira Ramasastry, M.Phil,M.S.
  • Independent Director
  • 597.63K
  • William Carl Fairey
  • Independent Director
  • 262.47K
  • Patrick J. Heron
  • Independent Director
  • 331.42K
  • Laura A. Brege
  • Independent Director
  • 354.30K
  • Dr. Lon Cardon, PhD
  • Independent Director
  • 440.64K
  • Dr. Pamela Vig, PhD
  • Head of Research and Development
  • 1.51M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg